The aerospace and defence manufacturing sectors in India are critical to the nation's self-reliance and technological advancement. The government has provided significant tax incentives for research and development activities in these sectors, including the deduction for in-house R&D expenditure under section 45(2) of the Income-tax Act, 2025. This provision encourages companies to invest in developing indigenous technologies and reduce dependence on imports.
Legal Framework
Statutory Provision
Section 45(2) provides for a deduction in respect of any expenditure on scientific research incurred (not being expenditure in the nature of cost of any land or building) by a company engaged in:
- The business of bio-technology; or
- The manufacture or production of any article or thing (not being specified in Schedule XIII)
The deduction is available for expenditure on in-house research and development facility as approved by the prescribed authority.
Prescribed Authority (Rule 29)
The prescribed authority for section 45(2) is the Secretary, Department of Scientific and Industrial Research, Government of India (DSIR).
Key Conditions for Eligibility
Company Engaged in Eligible Business
The company must be engaged in:
- Bio-technology; or
- Manufacture or production of any article or thing (other than articles/things specified in Schedule XIII)
Schedule XIII (Specified Articles/Things) The deduction is not available for manufacture or production of:
- Beer, wine and other alcoholic spirits
- Tobacco and tobacco preparations
- Cosmetics and toilet preparations
- Tooth paste, dental cream, tooth powder and soap
- Aerated waters using blended flavouring concentrates
- Confectionery and chocolates
- Gramophones and gramophone records
- Projectors
- Photographic apparatus and goods
- Office machines and apparatus (excluding computers)
- Steel furniture
- Safes, strong boxes, cash and deed boxes
- Latex foam sponge and polyurethane foam
- Crown corks or other fittings
- Pilfer-proof caps for packaging
In-House R&D Facility
The company must have an in-house research and development facility approved by the prescribed authority.
Agreement with Prescribed Authority
The company must enter into an agreement with the prescribed authority for co-operation in research and development facility.
Conditions for Approval
The approval of in-house R&D facility is subject to conditions including:
- The facility should not relate purely to market research, sales promotion, quality control, testing, commercial production, style changes, routine data collection or activities of a similar nature
- The company must maintain separate books of account for each approved facility
- The accounts must be audited annually
- The assets acquired by the approved facility shall be utilised only for the approved purpose
- The assets shall not be disposed of without the approval of the Secretary, DSIR
Approval Process
Application Procedure
Form 11 is required to be furnished for entering into an agreement with the prescribed authority.
Timing
- The application shall be made at any time during the financial year immediately preceding the tax year from which approval is sought
- In case of approval from the tax year in which the applicant is incorporated, the application may be made during that tax year
Documents Required
- Details of the company
- Description of the R&D facility
- Projected expenditure
- Proposed research activities
- Organisational structure of R&D facility
- Details of personnel
- Equipment and infrastructure
Order of Approval
The prescribed authority shall:
- If satisfied that the conditions are fulfilled, pass an order in writing in Form 14
- Approve the facility within four months from the end of the month in which application is received
- Furnish a copy of the order to the Chief Commissioner of Income-tax having jurisdiction over the company
Rejection
- If the application is rejected, a reasonable opportunity of being heard shall be granted to the company
Validity
The approval is effective for such period not exceeding five tax years as specified in the order.
Documentation and Reporting
Separate Books of Account
The company must maintain separate books of account for each approved facility.
Annual Audit
The accounts must be audited annually.
Form 13 - Report of audit to be furnished to the Secretary, DSIR:
- On or before the due date specified in section 263(1)(c)
- For each succeeding tax year
Annual Report
The company shall attach a copy of the audited annual account with the return of income.
Reflection in Financial Statements
The capital and revenue expenditure on in-house R&D facility must be reflected in the schedules or notes to accounts in the audited financial statement.
Reporting by Prescribed Authority
Part A of Form 12
The prescribed authority shall furnish a report in Part A of Form 12:
- In relation to the approval of in-house research and development facility
- Within 120 days of the grant of approval
Part B of Form 12
The prescribed authority shall furnish a report in Part B of Form 12:
- Quantifying the expenditure incurred on in-house R&D facility
- Eligible for deduction under section 45(2)
- Within 120 days of the submission of the audit report
Expenditure Eligible for Deduction
Nature of Expenditure
The deduction is available for:
- Revenue expenditure on scientific research
- Capital expenditure (other than cost of land or building) on scientific research
Expenditure on Scientific Research
Scientific research includes:
- Any activity for the extension of knowledge in the fields of natural or applied science
- Including agriculture, animal husbandry or fisheries
The expenditure must be:
- Incurred on in-house research and development facility
- Approved by the prescribed authority
- Related to the business of the company
Exclusions
The following are not eligible:
- Cost of any land or building
- Expenditure on market research, sales promotion, quality control, testing, commercial production, style changes, routine data collection or activities of a similar nature
- Expenditure for which deduction is claimed under any other provision
Special Provisions for Aerospace and Defence Sectors
Section 45(2) Benefits
Aerospace and defence manufacturers can claim deduction for:
- Research on new materials and composites
- Development of propulsion systems
- Avionics and electronics research
- Missile and weapon systems development
- Radar and sensor technology
- Communication systems
- Navigation and guidance systems
- Simulation and modelling
- Testing and evaluation facilities
- Certification and qualification facilities
Clinical Drug Trial and Regulatory Approval
For drugs and pharmaceuticals:
- Expenditure on clinical drug trial is included
- Expenditure on obtaining approval from regulatory authority is included
- Expenditure on filing application for patent under Patents Act, 1970 is included
Defence Sector Research
Research in the defence sector may include:
- Development of defence equipment and systems
- Research on materials for defence applications
- Development of indigenous technologies
- Prototype development and testing
- Technology demonstration
- Integration and certification
Withdrawal of Approval
The prescribed authority may withdraw the approval if:
- The facility ceases to exist
- The activities are not genuine
- The conditions are not fulfilled
Procedure
- Reasonable opportunity of being heard to be given
- Copy of order to be communicated to the company, Assessing Officer, and Chief Commissioner
Interplay with Other Provisions
Section 45(1) - Scientific Research Expenditure
Under section 45(1), deduction is available for:
- Capital expenditure (excluding cost of land) on scientific research related to the business
- Revenue expenditure on scientific research related to the business
Section 45(3) - Payment to Research Associations
Under section 45(3), deduction is available for:
- Payment to research associations, universities, colleges, or institutions
- Payment to approved companies for scientific research
- Payment to National Laboratories, Universities, or Indian Institutes of Technology
Section 45(7) - Unabsorbed Deduction
The provisions of section 33(11) apply to deductions allowable for capital expenditure under section 45(1). Unabsorbed deduction is carried forward and added to the depreciation allowance of the following year.
Section 45(10) - Amalgamation
Where an amalgamating company transfers an asset representing capital expenditure on scientific research to the amalgamated company, the provisions apply to the amalgamated company as they would have applied to the amalgamating company.
Strategic Considerations
Planning for Approval
- Identify R&D activities eligible for deduction
- Ensure activities are in the nature of scientific research
- Consider the timing of application for approval
- Prepare detailed documentation
Compliance Framework
- Maintain separate books of account
- Ensure annual audit
- File audit report within due date
- Reflect R&D expenditure in financial statements
Risk Management
- Ensure conditions of approval are fulfilled
- Monitor for any changes in circumstances
- Maintain proper documentation
- Seek professional advice on complex issues
Expert Advisory on R&D Deduction Compliance
Given the complexity of R&D deduction provisions and the importance of compliance for aerospace and defence manufacturers, professional advisory is essential. Anuj Desai & Associates provides comprehensive R&D deduction advisory services, including:
- Eligibility Assessment: Determining eligibility for R&D deduction
- Approval Assistance: Assistance with Form 11 application and approval process
- Documentation: Preparation and review of documentation
- Compliance: Assistance with maintenance of separate books, audit, and reporting
- Representation: Representation before the prescribed authority and income-tax authorities
- Dispute Resolution: Assistance with appeals and litigation
- Training: Training and awareness programmes on R&D deduction provisions
With deep expertise in R&D deduction provisions and thorough understanding of aerospace and defence manufacturing, Anuj Desai & Associates ensures that your R&D activities receive the maximum tax benefits while maintaining full compliance.
Need expert assistance with in-house R&D deduction compliance for your aerospace or defence manufacturing business? Contact Anuj Desai & Associates today for comprehensive advisory, application, and representation services. Our team of experienced tax professionals will help you maximise tax benefits from your R&D investments. [Contact Us] to schedule a consultation.